Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Combination Tablet Feasibility
NCT00000298Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Aug 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Started Aug 1995; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000298.